SHL Medical and Kindeva Partner to Expand Molly® Autoinjector Services

• SHL Medical and Kindeva Drug Delivery are partnering to provide fill-finish and pre-validated final assembly services for the Molly autoinjector platform.

• The collaboration will take place at Kindeva’s Bridgeton and Maryland Heights facilities, aiming to streamline supply chains and accelerate project timelines.

SHL Medical, a global provider of advanced drug delivery systems, has announced a strategic partnership with Kindeva Drug Delivery, a contract development and manufacturing organisation (CDMO), to enhance services for the Molly autoinjector platform. The agreement will establish fill-finish and pre-validated final assembly operations at Kindeva’s Bridgeton and Maryland Heights facilities.

The Molly autoinjector is a modular, single-dose drug delivery system designed to help pharmaceutical and biotechnology companies reduce upfront costs and accelerate product development. Through this collaboration, SHL Medical and Kindeva aim to improve efficiency, communication, and speed to market for drug products.

Kindeva, one of the few CDMOs capable of offering end-to-end services within a single geographic region, will contribute to a more streamlined and simplified supply chain. The partnership is expected to facilitate faster project completion and ensure the timely delivery of drug therapies.

Markus Puusepp, Chief Growth Officer at SHL Medical, commented, “We are excited to partner with Kindeva to further enhance the capabilities of our Molly autoinjector platform. This partnership will allow us to provide our customers with more efficient and comprehensive solutions, ultimately accelerating the delivery of innovative therapies to patients worldwide.”

Kindeva’s CEO, Milton Boyer, emphasised the collaboration’s patient-centric impact, stating that the partnership would improve access to treatments while optimising drug delivery operations. By integrating their expertise, SHL Medical and Kindeva seek to advance the development and manufacturing of innovative drug delivery solutions.